Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$24.72 -0.64 (-2.50%)
Closing price 10/7/2025 03:59 PM Eastern
Extended Trading
$24.70 -0.03 (-0.12%)
As of 10/7/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. PEN, STVN, IRTC, BLCO, GKOS, TMDX, SLNO, NVST, LIVN, and INSP

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Warby Parker currently has a consensus target price of $24.75, suggesting a potential upside of 0.10%. Penumbra has a consensus target price of $301.93, suggesting a potential upside of 21.24%. Given Penumbra's stronger consensus rating and higher probable upside, analysts clearly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
1 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.48
Penumbra
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.83

Warby Parker has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500.

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$821.35M3.17-$20.39M-$0.07-353.21
Penumbra$1.19B8.13$14.01M$3.7666.24

Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.12%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-1.12% -0.79% -0.41%
Penumbra 11.54%11.55%8.76%

In the previous week, Penumbra had 14 more articles in the media than Warby Parker. MarketBeat recorded 22 mentions for Penumbra and 8 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.32 beat Penumbra's score of 0.67 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
10 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by insiders. Comparatively, 5.0% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.67B$31.44B$15.70B$22.14B
Dividend YieldN/A2.75%3.23%3.57%
P/E Ratio-353.1637.4517.6829.64
Price / Sales3.171.9948.3095.37
Price / Cash74.7015.7114.5224.65
Price / Book7.388.017.094.61
Net Income-$20.39M$1.23B$680.75M$1.01B
7 Day Performance-9.03%-2.15%0.52%-0.14%
1 Month Performance-7.55%-5.94%1.18%2.28%
1 Year Performance51.41%15.60%-1.68%14.59%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.7299 of 5 stars
$24.73
-2.5%
$24.75
+0.1%
+50.6%$2.67B$821.35M-353.163,780Positive News
Analyst Forecast
PEN
Penumbra
4.6822 of 5 stars
$252.02
-0.5%
$302.93
+20.2%
+30.5%$9.88B$1.19B67.034,500Analyst Forecast
STVN
Stevanato Group
N/A€25.46
-0.8%
N/A+27.9%€7.71B€1.15B47.155,521
IRTC
iRhythm Technologies
1.1321 of 5 stars
$169.50
-0.8%
$167.50
-1.2%
+194.3%$5.49B$591.84M-57.852,000Analyst Forecast
BLCO
Bausch + Lomb
1.9787 of 5 stars
$14.98
+3.3%
$15.56
+3.9%
-22.0%$5.13B$4.79B-19.2013,500News Coverage
Analyst Forecast
GKOS
Glaukos
4.4717 of 5 stars
$81.24
+1.7%
$123.58
+52.1%
-33.3%$4.58B$383.48M-49.24780Analyst Forecast
TMDX
TransMedics Group
3.2398 of 5 stars
$112.64
-1.1%
$125.40
+11.3%
-14.1%$3.88B$441.54M58.36210Positive News
SLNO
Soleno Therapeutics
4.4066 of 5 stars
$68.16
+4.9%
$115.09
+68.9%
+30.4%$3.45BN/A-16.4630Analyst Forecast
Gap Up
NVST
Envista
3.7396 of 5 stars
$20.22
-0.7%
$20.92
+3.5%
+11.8%$3.38B$2.51B63.1712,300
LIVN
LivaNova
2.4878 of 5 stars
$52.33
-2.1%
$59.71
+14.1%
-1.0%$2.92B$1.25B-13.452,900
INSP
Inspire Medical Systems
4.8161 of 5 stars
$75.46
-2.3%
$154.43
+104.6%
-62.9%$2.28B$802.80M43.621,246Analyst Forecast

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners